(Q44454026)

English

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

clinical oncology

1 reference

based on heuristic

inferred from title

author name string

Jane T Hickok

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Joseph A Roscoe

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gary R Morrow

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

David K King

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

James N Atkins

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tom R Fitch

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2880-2886

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Nausea and emesis: evidence for a biobehavioral perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11408

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11408

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44454026&oldid=1531909489"